Comparison of the metabolic effects of eplerenone and spironolactone via plasma galectin-3 level in patients with heart failure

Hakan Göçer; Ahmet Barış Durukan; Mustafa Ünal

doi:10.5606/e-cvsi.2020.778

Num: 1 Vol: 7 Year: 2020

Current Issue Ahead of print Archive Search

Most Popular

A rare location for cardiac ... Surgical treatment of an iso ... Comparison of the sternal wi ... Aortic coarctation and desce ... Isolated insufficiency of th ... Comparison of conventional e ... Giant external iliac artery ... Removal of a missed guide wi ... Prosthetic mitral valve dehi ... Open abdominal surgery for m ... View All

Mitral valve replacement in ... Removal of a missed guide wi ... Surgical treatment of an iso ... Aortic coarctation and desce ... PERSPECTIVE FROM the EDITOR ... Comparison of conventional e ... Right anterior thoracotomy a ... Surgery of mitral valve dise ... A comparison of quality of l ... Surgery for patent ductus ar ... View All

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Cardiovascular Surgery and Interventions 2020, Vol 7, Num 1 Page(s): 003-007

Back | Table of Contents | PDF |

Comparison of the metabolic effects of eplerenone and spironolactone via plasma galectin-3 level in patients with heart failure

Hakan Göçer¹, Ahmet Barış Durukan², Mustafa Ünal³

¹Department of Cardiology, Medical Park Uşak Hospital, Uşak, Turkey
²Department of Cardiovascular Surgery, Medical Park Uşak Hospital, Uşak, Turkey
³Department of Cardiovascular Surgery, Bicard Clinic, Bishkek, Kyrgyzstan

Back | Table of Contents | PDF |